Connective Capital Management’s Ambrx Biopharma Inc AMAM Stock Holding History

Connective Capital Management’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-58,189	Closed	-$829K	–	97
2023 Q4	$829K	Buy	+58,189	New	+$661K	0.69%	25

Connective Capital Management's AMAM Position: Q1 2024 in Review

Connective Capital Management sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 58,189 shares — an estimated $829K sold.

Connective Capital Management first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $829K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Connective Capital Management reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Connective Capital Management sold 58,189 Ambrx Biopharma Inc shares in Q1 2024, an estimated $829K.
Connective Capital Management first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Connective Capital Management's Ambrx Biopharma Inc position peaked at $829K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Connective Capital Management's 13F filing for Q1 2024, filed 16 May 2024.